Myeloma Update from ASCO
SHARE
Share this Video
Dr. James Berenson, president of the Institute for Myeloma and Bone Cancer Research, updates us on the state of Myeloma treatment from the ASCO meeting in June 2011. Dr. Berenson tells us that life with Myeloma is now "a marathon, not a sprint" and describes the shifting focus to quality-of-life issues related to treatment. Topics in this interview include combination drug therapies and clinical trials for drugs Zometa and Xgeva. Dr. Berenson also touches on how quality-of-life issues should impact a patient's consideration of bone-marrow transplant. Overall, he offers an upbeat appraisal for patients living longer and better lives with Multiple Myeloma.
Health Topics: Multiple Myeloma
Get Email Updates:
Get updated automatically when new content about Multiple Myeloma has been posted.
Privacy Policy
Privacy Policy
Multiple Myeloma
Experts & Guests
|
James Berenson, M.D.
Founder, President and Medical and Scientific Director, Institute for Myeloma and Bone Cancer Research
James Berenson, M.D. is the Founder, President & Chief Executive Officer of the Institute for Myeloma and Bone Cancer Research. Dr. Berenson has specialized in research related to myeloma and metastatic bone disease both in the basic and clinical areas for more than 25 years. He has been involved in many of the major breakthroughs that have brought new treatments for...
more >
|
|
|
